NPI: 1306806260 · BALTIMORE, MD 21202 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/24/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/24/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 19,285 | $60K |
| 2019 | 17,687 | $107K |
| 2020 | 14,779 | $205K |
| 2021 | 14,779 | $203K |
| 2022 | 8,619 | $177K |
| 2023 | 7,119 | $202K |
| 2024 | 3,188 | $151K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 14,811 | 1,966 | $771K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 34,950 | 2,025 | $170K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 264 | 160 | $52K |
| 83970 | 1,855 | 1,698 | $39K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 15,113 | 1,498 | $36K |
| J1756 | Injection, iron sucrose, 1 mg | 5,048 | 1,364 | $35K |
| A4657 | Syringe, with or without needle, each | 4,624 | 2,375 | $4K |
| 84466 | 339 | 318 | $0.00 | |
| 85041 | 1,954 | 1,795 | $0.00 | |
| 85048 | 1,936 | 1,779 | $0.00 | |
| 83540 | 1,335 | 1,211 | $0.00 | |
| 90662 | 15 | 13 | $0.00 | |
| 82728 | 1,326 | 1,213 | $0.00 | |
| 83550 | 976 | 881 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 394 | 247 | $0.00 |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 90 | 55 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 57 | 54 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 341 | 334 | $0.00 |
| 82746 | 15 | 14 | $0.00 | |
| 82607 | 13 | 13 | $0.00 |